ArticleScientific reports2026
Effects of Rosa roxburghii and kiwifruit composite supplements on improving exercise performance and anti-fatigue in mice.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Rosa roxburghii Tratt (RR) and Actinidia chinensis Planch (AC, kiwifruit) are nutrient-dense plant foods with diverse bioactive components. This study aimed to evaluate the effect of supplementation with Rosa roxburghii and Kiwifruit (RRAC)on improving the exercise performance-enhancing and anti-fatigue effects of a RR-AC composite supplement (RRAC) in experimental murine models. Fifty male institute of Cancer Research (ICR) mice were randomly allocated to five groups (n = 10/group): (1) the blank control group (Rest, normal saline), (2) the fatigue model control group (Con, normal saline), (3) RRAC-L (130 mg/kg/d), (4) RRAC-M (260 mg/kg/d), (5) RRAC-H (520 mg/kg/d). Following 28 consecutive days intervention, the mice in all groups except the Rest group underwent a swimming exhaustion test. Then, mice were subsequently euthanized for plasma biochemical markers and analysis and tissue collection. We found that supplementation with 28-day RRAC could significantly enhance mice's exercise endurance performance, elevated hepatic and muscle glycogen content (all p < 0.05), and significantly reduced post-exercise fatigue biochemical parameters, including blood urea nitrogen (BUN), L-lactic acid (LAC), lactate dehydrogenase (LDH), creatine kinase (CK) concentration. Moreover, RRAC supplementation reduced the oxidative stress indicators malondialdehyde (MDA) activity, and increased the superoxide dismutase (SOD) , glutathione peroxidase (GSH-Px) (p < 0.05). In summary, supplementation with RRAC for 28 days could significantly enhance the exercise tolerance in mice during the swimming exhaustion test via glycogen accumulation and oxidative stress modulation, with no detectable adverse effects on organ structure or function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.